A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Clinical trial NCT06425159 · TERMINATED
Trial details
- NCT number
- NCT06425159
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2026-03-12
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.